RAPT Therapeutics, Inc. announced the promotion of Dirk Brockstedt, Ph.D., to chief scientific officer and David Wustrow, Ph.D., to senior vice president, drug discovery and preclinical development. Dirk Brockstedt, Ph.D., has been promoted to chief scientific officer. Dirk joined RAPT Therapeutics in January 2018 from Aduro Biotech, where he served as executive vice president of research and development. David Wustrow, Ph.D., has been promoted to senior vice president, drug discovery and preclinical development. David joined RAPT Therapeutics in 2016, bringing more than 20 years of experience in drug discovery. Most recently, David served as vice president, chemical and pharmaceutical sciences at Cleave Biosciences.